IFNG and neoplasm: Subsequent T-cell activation assays demonstrated that stimulation with the CD3 monoclonal antibody effectively induced robust T-cell activation and perfectly capable of killing tumor cells, accompanied by significant secretion of interferon-gamma (IFN-γ).